Trades on 1 secondary market

Grey Wolf Therapeutics

Grey Wolf Therapeutics (Greywolf Therapeutics) is a clinical-stage biotechnology company developing a new therapeutic class of immunotherapies through antigen modulation, aimed at treating people living with cancers and autoimmune disorders. Its approach modulates antigen presentation on cell surfac

minimal 10.2 / 100 0 APIs View provider profile →

Company Biotechnology Pharmaceuticals Immuno-oncology Immunotherapy Antigen Modulation

Grey Wolf Therapeutics is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.